BAKER BROS. ADVISORS LP 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-13 5:21 pm Purchase | 2025-06-12 | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,269,968 23.500% | 47,000 (+0.46%) | Filing |
| 2023-12-13 4:55 pm Purchase | 2023-12-11 | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,222,968 24.300% | 3,888 (+0.04%) | Filing |
| 2023-05-24 4:31 pm Purchase | 2023-05-18 | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,219,080 19.500% | 92,663 (+0.92%) | Filing |
| 2021-01-29 4:48 pm Purchase | 2021-01-22 | 13D | Prelude Therapeutics Incorporated PRLD | BAKER BROS. ADVISORS LP | 10,126,417 28.800% | 5,189 (+0.05%) | Filing |